Hani is the scientific founder of Therna Biosciences. He is a Core Investigator and AI research lead at the Arc Institute, where he is a key member of the team leading the Virtual Cell initiative, a monumental effort to build predictive, AI-driven models of cellular behavior. A pioneer at the intersection of machine learning and RNA biology, he also serves as an Associate Professor at UCSF in the Department of Biochemistry and Biophysics and is a member of the Bakar Computational Health Sciences Institute. Since establishing his lab in 2016, Hani has focused on decoding the complex “RNA code”, developing foundational computational models for single-cell sequencing and multimodal data integration.

He is the founder of two other biotech companies, Exai Bio and Tahoe Therapeutics. A recipient of the Vilcek Prize for Creative Promise, the AACR-MPM Transformative Cancer Research Award, and the Martin and Rose Wachtel Award, Hani is dedicated to bridging computational theory and experimental biology to drive the next generation of human health breakthroughs.

Hani got his Ph.D. from Princeton and completed his post-doctoral training at Rockefeller University.